REGN vs TASK
Regeneron Pharmaceuticals Inc (REGN) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the REGN and TASK stock pages for the full models.
Not investment advice.